与大豆油相比,米糠油与芝麻油混合可能的抗糖尿病和抗高脂血症疗效:糖尿病前期和糖尿病患者的临床研究

D. Hota, An, Srinivasan, J. Sahoo, Kishore Behera, B. Patro, B. Debapriya, Yopadhyay, R. Sehgal
{"title":"与大豆油相比,米糠油与芝麻油混合可能的抗糖尿病和抗高脂血症疗效:糖尿病前期和糖尿病患者的临床研究","authors":"D. Hota, An, Srinivasan, J. Sahoo, Kishore Behera, B. Patro, B. Debapriya, Yopadhyay, R. Sehgal","doi":"10.35248/2167-0870.20.10.419","DOIUrl":null,"url":null,"abstract":"Objective: Cooking oil is an important ingredient of the diet and type of cooking oil used can affect the incidence and progression of metabolic disorders. It is established that mono and polyunsaturated fatty acids lowers the risk of diabetes or helps in better management of diabetes. The blend of rice bran oil and sesame oil contains PUFA and MUFA in nearly recommended levels. The present study was planned to evaluate and validate effect of blend of Rice BranOil and Sesame Oil (RBSO) in subjects with type II diabetes. Research design and methods: Fifty one diabetic patients were randomized to receive either Fortune vivo blended rice-bran oil (RBSO; n=26) or the comparator soybean oil (n=25). RBSO was given to 29 non-diabetic, 28 pre-diabetic controls. The amount of cooking oils was given for the entire family as per the recommended daily dietary requirement for 12 weeks. Following 12 weeks of study and a subsequent wash-out period of 21 days, 12 patients were randomly selected from each arm of the 2 diabetic patient groups and were crossed over to receive the other study oil and evaluated every 4 weeks for another 12 weeks in a similar manner as before. Results: There was reduction in FBS and PPBS across all RBSO groups, but was significant only in the diabetic patients (p=0.010). There was no significant change in FBS or PPBS levels observed in soybean oil treated group. RBSO treated diabetic group showed 9.5% reduction of HbA1c while it was elevated in the soybean oil group. Both RBSO and soybean oil were well tolerated by all subjects and no adverse event was noted in any study group. Conclusion: In the present study, RBSO appeared to improve sugar metabolism as evidenced by reduction in FBS, PPBS and HbA1c in type-2 diabetic patients.","PeriodicalId":15375,"journal":{"name":"Journal of clinical trials","volume":"36 5 1","pages":"1-10"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Possible Anti-Diabetic and Anti-Hyperlipidemic Efficacy of Blended Rice Bran Oil with Sesame Oil in Comparison with Soybean Oil: A Clinical Investigation in Pre-Diabetic and Diabetic Individuals\",\"authors\":\"D. Hota, An, Srinivasan, J. Sahoo, Kishore Behera, B. Patro, B. Debapriya, Yopadhyay, R. Sehgal\",\"doi\":\"10.35248/2167-0870.20.10.419\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Cooking oil is an important ingredient of the diet and type of cooking oil used can affect the incidence and progression of metabolic disorders. It is established that mono and polyunsaturated fatty acids lowers the risk of diabetes or helps in better management of diabetes. The blend of rice bran oil and sesame oil contains PUFA and MUFA in nearly recommended levels. The present study was planned to evaluate and validate effect of blend of Rice BranOil and Sesame Oil (RBSO) in subjects with type II diabetes. Research design and methods: Fifty one diabetic patients were randomized to receive either Fortune vivo blended rice-bran oil (RBSO; n=26) or the comparator soybean oil (n=25). RBSO was given to 29 non-diabetic, 28 pre-diabetic controls. The amount of cooking oils was given for the entire family as per the recommended daily dietary requirement for 12 weeks. Following 12 weeks of study and a subsequent wash-out period of 21 days, 12 patients were randomly selected from each arm of the 2 diabetic patient groups and were crossed over to receive the other study oil and evaluated every 4 weeks for another 12 weeks in a similar manner as before. Results: There was reduction in FBS and PPBS across all RBSO groups, but was significant only in the diabetic patients (p=0.010). There was no significant change in FBS or PPBS levels observed in soybean oil treated group. RBSO treated diabetic group showed 9.5% reduction of HbA1c while it was elevated in the soybean oil group. Both RBSO and soybean oil were well tolerated by all subjects and no adverse event was noted in any study group. Conclusion: In the present study, RBSO appeared to improve sugar metabolism as evidenced by reduction in FBS, PPBS and HbA1c in type-2 diabetic patients.\",\"PeriodicalId\":15375,\"journal\":{\"name\":\"Journal of clinical trials\",\"volume\":\"36 5 1\",\"pages\":\"1-10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/2167-0870.20.10.419\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2167-0870.20.10.419","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

目的:食用油是饮食的重要成分,食用油的种类会影响代谢紊乱的发生和发展。单不饱和脂肪酸和多不饱和脂肪酸可以降低患糖尿病的风险或有助于更好地控制糖尿病。米糠油和芝麻油的混合物含有接近推荐水平的多聚脂肪酸和多聚脂肪酸。本研究旨在评价和验证米糠油和芝麻油(RBSO)对2型糖尿病患者的治疗效果。研究设计与方法:将51例糖尿病患者随机分为两组,一组为Fortune vivo混合米糠油(RBSO;N =26)或比较物大豆油(N =25)。对照组29例非糖尿病患者,28例糖尿病前期患者。在12周的时间里,按照推荐的每日膳食需求给整个家庭提供食用油的量。经过12周的研究和随后21天的洗脱期,从两组糖尿病患者中随机选择12名患者,并交叉接受另一组研究油,并以与之前相似的方式每4周评估一次,持续12周。结果:在所有RBSO组中,FBS和PPBS均有降低,但仅在糖尿病患者中有显著性差异(p=0.010)。大豆油处理组FBS和PPBS水平无显著变化。RBSO治疗糖尿病组HbA1c降低9.5%,豆油组HbA1c升高。所有受试者对RBSO和大豆油均有良好的耐受性,在任何研究组均未发现不良事件。结论:在本研究中,RBSO似乎可以改善糖代谢,这可以通过降低2型糖尿病患者的FBS、PPBS和HbA1c来证明。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Possible Anti-Diabetic and Anti-Hyperlipidemic Efficacy of Blended Rice Bran Oil with Sesame Oil in Comparison with Soybean Oil: A Clinical Investigation in Pre-Diabetic and Diabetic Individuals
Objective: Cooking oil is an important ingredient of the diet and type of cooking oil used can affect the incidence and progression of metabolic disorders. It is established that mono and polyunsaturated fatty acids lowers the risk of diabetes or helps in better management of diabetes. The blend of rice bran oil and sesame oil contains PUFA and MUFA in nearly recommended levels. The present study was planned to evaluate and validate effect of blend of Rice BranOil and Sesame Oil (RBSO) in subjects with type II diabetes. Research design and methods: Fifty one diabetic patients were randomized to receive either Fortune vivo blended rice-bran oil (RBSO; n=26) or the comparator soybean oil (n=25). RBSO was given to 29 non-diabetic, 28 pre-diabetic controls. The amount of cooking oils was given for the entire family as per the recommended daily dietary requirement for 12 weeks. Following 12 weeks of study and a subsequent wash-out period of 21 days, 12 patients were randomly selected from each arm of the 2 diabetic patient groups and were crossed over to receive the other study oil and evaluated every 4 weeks for another 12 weeks in a similar manner as before. Results: There was reduction in FBS and PPBS across all RBSO groups, but was significant only in the diabetic patients (p=0.010). There was no significant change in FBS or PPBS levels observed in soybean oil treated group. RBSO treated diabetic group showed 9.5% reduction of HbA1c while it was elevated in the soybean oil group. Both RBSO and soybean oil were well tolerated by all subjects and no adverse event was noted in any study group. Conclusion: In the present study, RBSO appeared to improve sugar metabolism as evidenced by reduction in FBS, PPBS and HbA1c in type-2 diabetic patients.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信